D. Bruce Burlington, M.D.

Executive Vice President, Business Practices and Compliance
Wyeth Pharmaceuticals

Bruce Burlington, M.D. is Executive Vice President for Business Practices and Compliance at Wyeth Pharmaceuticals located in Collegeville, Pennsylvania.  Through various governance committees, he is broadly involved in Wyeth’s management. Previously at Wyeth, he supervised the Regulatory Affairs, Safety Surveillance, Quality Operations, Compliance Operations, and Audit Departments.

Dr. Burlington joined Wyeth in March 1999 from the U.S. Food and Drug Administration where he was a research fellow, Chief of the Influenza Vaccines Lab, and then led the Investigational New Drug Division in the Center for Biologics.  He moved to the Center for Drug’s New Drug Evaluation program in 1988 and was acting Deputy Center Director for Medical Affairs from 1991 through 1993.  Between 1993 and 1999 he managed the FDA’s Center for Medical Devices and Radiological Health, which oversees the U.S.’s regulatory programs for medical devices, in vitro diagnostic products, radiological health, and mammography quality.  During his career at the FDA, Dr. Burlington continued a part-time emergency medicine practice at the Arlington Hospital.

A graduate of Louisiana State University School of Medicine at New Orleans, Dr. Burlington received his clinical training at the University of Colorado, and is board certified in Internal Medicine and Infectious Diseases.